CSBR and BDSX ride on distinct oncology growth drivers, but which stock looks more compelling amid contrasting performance and valuations? Let's dive in.
APA raises its 2026 free cash flow outlook to $2.9B, targets lower debt and plans higher 2027 spending to advance Suriname development and exploration projects.
NIKE's fiscal 2027 outlook signals lower sales and earnings pressure, while its $2.5 billion Pace savings plan offers longer-term benefits amid near-term risks.
NIKE shares surged 13.9% in a month as performance categories and North America gained traction, but China weakness and earnings pressure cloud the turnaround.
Natural Resource Partners' Q3 earnings decline y/y amid soda ash weakness, but strong cash flow, lower debt and a higher distribution aid financial flexibility.
Hamilton Beach Brands reports higher y/y earnings and revenues in Q3 but cuts its 2026 outlook amid cautious retailer spending and softer consumer demand.
Vince, ASE Technology, Orange County Bancorp and The GEO Group stand out for strong net profit margins, with rising earnings estimates adding to their appeal.
10x Genomics raises its 2026 revenue outlook on strong Atera demand and spatial consumables growth, but production constraints and margin pressure remain challenges.
While the top- and bottom-line numbers for TDS (TDS) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
The headline numbers for Telus (TU) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
BlackRock, Ameriprise and Invesco are leveraging ETF inflows, wealth management demand and strategic expansion to navigate fee pressure and rising industry costs.
Axon cuts its 2026 revenue outlook amid federal counter-drone delays, even as AI adoption, software growth and a $1.2 billion Skydio investment fuel expansion.
Hasbro and JAKKS Pacific are capitalizing on licensed franchises, collectibles and product innovation, with strong brand demand and expanding offerings driving growth.
Energy Fuels advances its mine-to-magnet strategy with rare earth expansions and acquisitions, while uranium profitability offsets operational and funding challenges.
Nexxen, NIQ and National CineMedia are tapping AI, connected TV and digital out-of-home advertising to capture shifting budgets and demand for measurable campaign results.
Aflac, Unum, Globe Life, Trupanion and Employers Holdings face medical cost inflation and pricing pressure, but rising demand for supplemental coverage offers growth opportunities.
ACM Research raises its 2026 revenue outlook as Q3 sales climb 36.6%, backed by a $2.5B backlog, stronger equipment orders and expanding global demand.